Mucormycosis diagnosed during induction chemotherapy in five pediatric patients with acute lymphoblastic leukemia
暂无分享,去创建一个
[1] N. Santoro,et al. Invasive mucormycosis in children with cancer: A retrospective study from the Infection Working Group of Italian Pediatric Hematology Oncology Association , 2018, Mycoses.
[2] D. Kuo,et al. Severe Neuropathic Pain With Concomitant Administration of Vincristine and Posaconazole. , 2018, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
[3] M. Arendrup,et al. Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature , 2018, Mycopathologia.
[4] M. Ertem,et al. Toxicity of Vincristine Combined With Posaconazole in Children With Acute Lymphoblastic Leukemia , 2017, Journal of pediatric hematology/oncology.
[5] J. Duchin,et al. Seasonal clustering of sinopulmonary mucormycosis in patients with hematologic malignancies at a large comprehensive cancer center , 2017, Antimicrobial Resistance & Infection Control.
[6] P. Escribano,et al. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates , 2017, PloS one.
[7] D. Seidel,et al. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries , 2016, BMC Infectious Diseases.
[8] A. Borkhardt,et al. Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] D. Kontoyiannis,et al. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[10] G. Lenz,et al. Epileptic seizures and rhinocerebral mucormycosis during blinatumomab treatment in a patient with biphenotypic acute leukemia , 2016, Annals of Hematology.
[11] A. Velegraki,et al. A Prospective, International Cohort Study of Invasive Mold Infections in Children. , 2015, Journal of the Pediatric Infectious Diseases Society.
[12] S. Balajee,et al. Mucormycosis Outbreak Associated With Hospital Linens , 2014, The Pediatric infectious disease journal.
[13] Sandeep Jain,et al. Successful outcome of mucormycosis in two children on induction therapy for acute lymphoblastic leukemia , 2013, Indian Journal of Medical and Paediatric Oncology.
[14] B. Moriyama,et al. Adverse interactions between antifungal azoles and vincristine: review and analysis of cases , 2012, Mycoses.
[15] D. Kontoyiannis,et al. How I treat mucormycosis. , 2011, Blood.
[16] S. Kabra,et al. ‘Primary cutaneous mucormycosis during induction chemotherapy in a child with acute lymphoblastic leukemia’ , 2009, Indian journal of pediatrics.
[17] J. Desenclos,et al. Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006 , 2009, Emerging infectious diseases.
[18] Russell E. Lewis,et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. , 2005, The Journal of infectious diseases.
[19] J. Englund,et al. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.